drugset / Trial / NCT06376916
Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this prospective, randomized, double-blinded study is to further evaluate the safety and efficacy of varying doses of intravenous magnesium in the treatment of AFF RVR.
Timeline
- Start
- 2024-10-07
- Primary completion
- 2026-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Magnesium Sulfate | Other / unclassified | 2 g | Intravenous |
| Subject | Magnesium Sulfate | Other / unclassified | 4 g | Intravenous |